ThinkstockPhotos-160337891 low sat purpl

About Us

Headquartered in Pittsburgh, Helomics is a division of Predictive Oncology Inc. Our mission is to improve outcomes for current and future cancer patients using a knowledge and AI-driven approach. We leverage our proprietary tumor profiling platform, a vast historical knowledgebase of 150,000 de-identified patient drug response profiles together with proven AI to deliver more precisely targeted therapies for patients.

 

For clinicians and their patients, we provide a proprietary clinically validated tumor profiling test to help oncologists individualize the treatment of GYN cancer patients with current therapies.

For Pharmaceutical partners, we improve the efficiency and cost-effectiveness of the discovery of new therapies, using a unique AI-driven, patient-centric approach